January 9, 2025 - 17:10

In a significant move to enhance its portfolio, Synaffix, a leader in antibody-drug conjugate (ADC) technology, has entered into a new licensing agreement with Boehringer Ingelheim. This partnership allows Boehringer to leverage Synaffix's advanced ADC technologies for a specified number of cancer targets, although the exact details regarding the number of targets remain confidential.
This agreement marks a strategic step for Synaffix as it continues to build on its momentum from last year, when it secured several partnerships. Additionally, Synaffix has expanded its collaboration network by forming a technology licensing deal with Mitsubishi Tanabe Pharma in Japan. These developments underscore Synaffix's commitment to advancing cancer treatment options through innovative ADC technologies.
As the landscape of cancer therapeutics evolves, this collaboration with Boehringer Ingelheim is poised to accelerate the development of novel ADC therapies, potentially leading to more effective treatment solutions for patients battling cancer.
December 21, 2025 - 12:52
MACOM Technology Solutions: Implications of Optical Interconnect Growth for InvestorsRecently, MACOM Technology Solutions has garnered attention for its impressive revenue and earnings growth, particularly in the realm of next-generation optical connectivity. The company is making...
December 20, 2025 - 19:26
Emerging Global Hubs for Robotics and FinanceFor much of the past half-century, Silicon Valley has been synonymous with technological innovation, particularly in computing, semiconductors, and software. However, a shift is underway as cities...
December 20, 2025 - 02:22
NASA's New Technology Allows Seamless Communication in Space MissionsJust like your cellphone stays connected by roaming between networks, NASA’s Polylingual Experimental Terminal, or PExT, technology demonstration is proving space missions can do the same by...
December 19, 2025 - 08:21
MIT Senior Innovates with Community-Focused TechnologiesJulia Schneider, a senior at MIT, is making waves by harnessing her technical skills to address pressing issues within her community. Her journey began at the Biomimetic Robotics Lab, where she...